Medtronic introduces implantable neurostimulation system
Medtronic Inc. recently introduced in Europe the first implantable neurostimulation systems indicated for use in the treatment of chronic back or leg pain that are designed for full-body MRI scans under specific conditions.
The neurostimulation systems recently received a CE mark approval for the treatment of chronic pain. According to a company press release, the Medtronic SureScan neurostimulation systems include enhancements to existing devices as well as specially designed leads to reduce or eliminate the hazards produced by the MRI environment. The devices also include a proprietary SureScan programming feature, which sets the device into an appropriate mode for the MRI environment.